Zymeworks develops antibody medicines for cancer and immune diseases and partners with drugmakers to sell them. It last closed at $26.14 on Nov 20, down 2.68% on the day. The next earnings report for ZYME is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, ZYME reported EPS of $2.28 on revenue of $256.5M, with revenue up 828.7% from a year ago. Over its last 8 reports the stock moved an average of 3.3% the session after earnings. Over the last 12 months ZYME insiders bought $0 of stock on the open market and sold $6.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is ZYME in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ZYME.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ZYMEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ZYME · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 8% below its 20 day and 4% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the swing low (Sep 15) at $25.81, and the nearest resistance the swing high (May 27) at $26.19.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.5%/day
Key levels
$31.9752 week high+22.3%
$28.3620 day average+8.5%
$27.2050 day average+4.1%
$27.11Pivot R1+3.7%
$26.60Pivot+1.8%
$26.43100 day average+1.1%
$26.19Swing high (May 27)+0.2%
$26.14Last close
$25.81Swing low (Sep 15)−1.3%
$25.63Pivot S1−2.0%
$25.61200 day average−2.0%
$21.5252 week low−17.7%
Indicators
RSI (14)
43.08
Middle of its range
Neutral
MACD
-0.31
Below its signal line
Bearish
Stochastic
20.9
Middle of its range
Neutral
ADX (14)
19.3
No clear trend
Williams %R
-82.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-87.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.8%
Change over 10 sessions
Bearish
ATR (14)
$1.44
Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 11.1%/day
Key levels
$31.9752 week high+22.3%
$28.3620 day average+8.5%
$27.2050 day average+4.1%
$27.11Pivot R1+3.7%
$26.60Pivot+1.8%
$26.43100 day average+1.1%
$26.19Swing high (May 27)+0.2%
$26.14Last close
$25.81Swing low (Sep 15)−1.3%
$25.63Pivot S1−2.0%
$25.61200 day average−2.0%
$21.5252 week low−17.7%
Indicators
RSI (14)
50.53
Middle of its range
Neutral
MACD
0.77
Below its signal line
Bearish
Stochastic
44.9
Middle of its range
Neutral
ADX (14)
28.1
Trending up
Williams %R
-79.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-6.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.4%
Change over 10 sessions
Bearish
ATR (14)
$2.91
Typical daily range, 11.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ZYME
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ZYME did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ZYME usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ZYMEHow many large options trades hit ZYME, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ZYME in the last 90 days.
From SEC Form 4 filings by ZYME's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ZYME is in one of them and how their past ZYME trades turned out.
Zymeworks is a biotechnology company based in Middletown, Delaware. It develops medicines built from antibodies for cancer, inflammation and autoimmune disease, using its own technology platforms. Its partners are drugmakers that share development costs and sell the treatments, and Zymeworks earns milestone payments and royalties from those partnerships.